肿瘤分子靶向治疗药物的发展概况  

The development of targeted anti-cancer therapy

作　　者：郭子寒 杜琼[1,2,3] 戴贤春 刘莹莹 余波 翟青[1,2,3] 

机构地区：[1]复旦大学上海医学院肿瘤学系,上海200032 [2]复旦大学附属肿瘤医院药剂科,上海200032 [3]复旦大学附属肿瘤医院质子重离子中心,上海201321

出　　处：《上海医药》2018年第5期5-9,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：肿瘤分子靶向治疗药物具有作用选择性和安全性高等优点,在癌症治疗中发挥着重要作用。美国FDA至今共批准了66种肿瘤分子靶向治疗药物。本文就肿瘤分子靶向治疗药物的发展概况作一简要介绍。Targeted anti-cancer therapy is highly selective and safe, which plays an important role in cancer therapy. Sixty-six kinds of molecular targeted drugs have been approved by FDA. In this paper, we review the latest development of molecular targeted cancer therapy.

关 键 词：癌症 分子靶向治疗 发展概况 

分 类 号：R979.19[医药卫生—药品]